株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙SALE
市場調査レポート

幹細胞バンクの世界市場:2018年〜2022年

Global Stem Cell Banking Market 2018-2022

発行 TechNavio (Infiniti Research Ltd.) 商品コード 341748
出版日 ページ情報 英文 113 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.58円で換算しております。
Back to Top
幹細胞バンクの世界市場:2018年〜2022年 Global Stem Cell Banking Market 2018-2022
出版日: 2018年01月02日 ページ情報: 英文 113 Pages
概要

幹細胞バンクについて

世界の幹細胞バンク市場は、再生医療市場と密接に関連した市場です。再生医療は現代医学の重要な分野であり、組織工学と分子生物学の組み合わせとして登場しました。再生医療は、障害のある細胞、組織または器官を、正常な機能に戻したり回復することができるヒトの細胞、組織または器官を再構築することを目的とします。

Technavioのアナリストは、世界の幹細胞バンク市場は、2018年から2022年の期間に12.76%のCAGRで成長すると予測しています。

当レポートでは、世界の幹細胞バンク市場について調査分析し、市場規模と成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 調査範囲

第3章 調査方法

第4章 市場状況

  • 市場の生態系
  • 市場特性
  • 市場セグメンテーション分析

第5章 市場規模

  • 市場の定義
  • 市場規模
  • 市場規模と予測

第6章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入者の脅威
  • 代替品の脅威
  • 競争相手の脅威
  • 市場状況

第7章 市場セグメンテーション:細胞タイプ別

  • 概要
  • 比較:細胞タイプ別
  • 成体幹細胞
  • 臍帯血幹細胞
  • 胚性幹細胞
  • 市場機会:細胞タイプ別

第8章 顧客情勢

第9章 地域情勢

  • 地理的セグメンテーション
  • 地域比較
  • 南北アメリカ
  • 欧州・中東・アフリカ地域
  • アジア太平洋地域
  • 市場機会

第10章 意思決定の枠組み

第11章 成長要因と課題

  • 市場の成長要因
  • 市場の課題

第12章 市場動向

  • 無機的成長戦略の強化
  • オーダーメイド医薬品需要の高まり
  • 幹細胞療法の受入れ拡大

第13章 ベンダー情勢

  • 競合シナリオ

第14章 ベンダー分析

  • 対象ベンダー
  • ベンダーの分類
  • ベンダーの市場ポジショニング
  • AMAG Pharmaceuticals
  • Cordlife
  • Cryo-Cell International
  • Esperite
  • 他の有力なベンダー

第15章 付録

  • 略語リスト
図表
  • Exhibit 01: Global stem cell banking market: Related market
  • Exhibit 02: Global stem cell banking market: Market characteristics
  • Exhibit 03: Global stem cell banking market: Market segments
  • Exhibit 04: Market definition: Inclusions and exclusions checklist
  • Exhibit 05: Global stem cell banking market: Market size 2017
  • Exhibit 06: Validation techniques employed for market sizing 2017
  • Exhibit 07: Global stem cell banking market: Market size and forecast 2017-2022 ($ billions)
  • Exhibit 08: Global stem cell banking market: Year-over-year growth 2017-2022 (%)
  • Exhibit 09: Five forces analysis 2017
  • Exhibit 10: Five forces analysis 2022
  • Exhibit 11: Bargaining power of suppliers
  • Exhibit 12: Threat of new entrants
  • Exhibit 13: Threat of substitutes
  • Exhibit 14: Threat of rivalry
  • Exhibit 15: Market condition: Five forces 2017
  • Exhibit 16: Market condition: Five forces 2022
  • Exhibit 17: Global stem cell banking market: Segmentation by cell type 2017-2022 (% share)
  • Exhibit 18: Global stem cell banking market: Comparison by cell type
  • Exhibit 19: Global adult stem cell banking market 2017-2022 ($ billions)
  • Exhibit 20: Global adult stem cell banking market: Year-over-year growth 2018-2022 (%)
  • Exhibit 21: Global umbilical cord blood stem cell banking market 2017-2022 ($ billions)
  • Exhibit 22: Global umbilical cord blood stem cell banking market: Year-over-year growth 2018-2022 (%)
  • Exhibit 23: Global embryonic stem cell banking market 2017-2022 ($ billions)
  • Exhibit 24: Global embryonic stem cell banking market: Year-over-year growth 2018-2022 (%)
  • Exhibit 25: Global stem cell banking market: Market opportunity by cell type
  • Exhibit 26: Global stem cell banking market: Customer landscape
  • Exhibit 27: Global stem cell banking market: Segmentation by geography 2017-2022 (% share)
  • Exhibit 28: Regional comparison
  • Exhibit 29: Stem cell banking market in Americas 2017-2022 ($ billions)
  • Exhibit 30: Stem cell banking market in Americas: Year-over-year growth 2018-2022 (%)
  • Exhibit 31: Top three countries in Americas
  • Exhibit 32: Stem cell banking market in EMEA 2017-2022 ($ billions)
  • Exhibit 33: Stem cell banking market in EMEA: Year-over-year growth 2018-2022 (%)
  • Exhibit 34: Top three countries in EMEA
  • Exhibit 35: Stem cell banking market in APAC 2017-2022 ($ billions)
  • Exhibit 36: Stem cell banking market in APAC: Year-over-year growth 2018-2022 (%)
  • Exhibit 37: Top three countries in APAC
  • Exhibit 38: Cancer severity across EU in 2013 and cancer incidence in US in 2014
  • Exhibit 39: Year-over-Year growth and growth rate of stem cell research spending in US 2013-2016 ($ billions)
  • Exhibit 40: CIRM funding in stem cell research 2014 ($ billions)
  • Exhibit 41: CIRM active programs 2014
  • Exhibit 42: EC funding for regenerative medicine
  • Exhibit 43: Strategic success factors of vendors in market
  • Exhibit 44: Vendor classification
  • Exhibit 45: Market positioning of vendors
  • Exhibit 46: AMAG Pharmaceuticals: Overview
  • Exhibit 47: AMAG Pharmaceuticals: Business segments
  • Exhibit 48: AMAG Pharmaceuticals: Organizational developments
  • Exhibit 49: AMAG Pharmaceuticals: Geographic focus
  • Exhibit 50: AMAG Pharmaceuticals: Segment focus
  • Exhibit 51: AMAG Pharmaceuticals: Key offerings
  • Exhibit 52: Cordlife: Overview
  • Exhibit 53: Cordlife: Business segments
  • Exhibit 54: Cordlife: Organizational developments
  • Exhibit 55: Cordlife: Geographic focus
  • Exhibit 56: Cordlife: Segment focus
  • Exhibit 57: Cordlife: Key offerings
  • Exhibit 58: Cryo-Cell International: Overview
  • Exhibit 59: Cryo-Cell International: Business segments
  • Exhibit 60: Cryo-Cell International: Organizational developments
  • Exhibit 61: Cryo-Cell International: Geographic focus
  • Exhibit 62: Cryo-Cell International: Segment focus
  • Exhibit 63: Cryo-Cell International: Key offerings
  • Exhibit 64: Esperite: Overview
  • Exhibit 65: Esperite: Business segments
  • Exhibit 66: Esperite: Organizational developments
  • Exhibit 67: Esperite: Geographic focus
  • Exhibit 68: Esperite: Segment focus
  • Exhibit 69: Esperite: Key offerings
目次
Product Code: IRTNTR20140

About Stem Cell Banking

The global stem cell banking market is a closely related market to the global regenerative medicine market. Regenerative medicine is a key branch of modern medicine, which has emerged as a combination of tissue engineering and molecular biology. Regenerative medicine aims to re-engineer human cells, tissues, or organs, which can replace or restore the normal functioning of impaired cells, tissues; or organs.

Technavio's analysts forecast the global stem cell banking market to grow at a CAGR of 12.76% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global stem cell banking market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Stem Cell Banking Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • AMAG Pharmaceuticals
  • Cordlife
  • Cryo-Cell International
  • Esperite

Other Prominent Vendors

  • Cellular Dynamics International
  • China Cord Blood Corporation
  • Cordvida
  • Cryo Stemcell
  • Cryoviva India
  • Cytori Therapeutics
  • Lifecell
  • PerkinElmer
  • Reelabs
  • Smart Cells International
  • Stemade Biotech
  • StemCyte

Market driver

  • Growing prevalence of cancer
  • For a full, detailed list, view our report

Market trend

  • Growing acceptance of stem cell therapies
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY CELL TYPE

  • Overview
  • Comparison by cell type
  • Adult stem cells
  • Umbilical cord blood stem cells
  • Embryonic stem cells
  • Market opportunity by cell type

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Stem cell banking market in Americas
  • Stem cell banking market in EMEA
  • Stem cell banking market in APAC
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Increasing implementation of inorganic growth strategies
  • Rising demand for personalized medicines
  • Growing acceptance of stem cell therapies

PART 13: VENDOR LANDSCAPE

  • Competitive scenario

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • AMAG Pharmaceuticals
  • Cordlife
  • Cryo-Cell International
  • Esperite
  • Other prominent vendors

PART 15: APPENDIX

  • List of abbreviations
Back to Top